# Pregabalin for the Treatment of Pain After Posterior Spinal Fusions

> **NCT01366196** · NA · COMPLETED · sponsor: **Hospital for Special Surgery, New York** · enrollment: 86 (actual)

## Conditions studied

- Lumbar Spinal Fusions

## Interventions

- **DRUG:** Pregabalin 150 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01366196
- **Lead sponsor:** Hospital for Special Surgery, New York
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2022-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01366196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01366196, "Pregabalin for the Treatment of Pain After Posterior Spinal Fusions". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01366196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*